Molina Healthcare IncNYSE: MOH
Health Care · Managed Health Care
$192.82
-0.92%
Vol: 841K
Research Digest
Friday, May 1, 2026
Molina Healthcare surges 5.7% on analyst upgrades; double upgraded by BofA to Buy
Molina surged 5.7% on Tuesday as five major Wall Street firms raised price targets. BofA double-upgraded from Underperform to Buy. Truist raised to $180 from $145. Q1 EPS $2.35 adjusted (beat), served 5.0M members, premium revenue $10.2B. Company reaffirmed FY2026 guidance: $42B revenue, EPS at least $5.00. Investor Day May 8 to update 3-year outlook. Stock up 18.32% week-over-week, +23.55% month-over-month.
Previous Market Intelligence
13 daysApr 30Molina Healthcare beats Q1 earnings, reaffirms FY guidance despite Medicaid headwindsPositive▶
Molina Healthcare reported Q1 2026 adjusted EPS of $2.35, beating analyst estimates of $1.94, and reaffirmed full-year adjusted EPS guidance despite revenue declining 3.1% YoY to $10.8B. The company exited MAPD product for 2027 and increased Medicaid membership attrition guidance to 6%. Stock surged 13-17% on earnings beat.
Apr 16Molina Healthcare invests $400K in Nevada behavioral health services; 2027 MA rates finalizedNeutral▶
Molina Healthcare announced a $400,000 investment in enhanced behavioral health services in Nevada on April 14. Q1 2026 earnings are scheduled for April 22 with a conference call on April 23. CMS has finalized higher 2027 Medicare Advantage payment rates. The stock is up 6.2% over the past week but down 20.7% YTD. Molina is expected to report a 74.2% decline in EPS to $1.57.
Apr 152027 Medicare Advantage rates finalized at higher levels; Molina Healthcare faces margin pressure despite membership growth.Mixed▶
CMS finalized 2027 Medicare Advantage payment rates at higher reimbursement levels, supporting Molina's outlook. Company reported disappointing Q4 2025 with 94.6% medical cost ratio and net loss, slashing 2026 EPS guidance to $5.00. Despite challenges, 90-day return of 19.77% and 1-year total return of 57.72% reflect recent momentum. MOH has grown to 5.7 million members with 9% year-over-year increase. Hold consensus from 14 analysts with target of $157.15.
Apr 14Molina Healthcare reaffirms 2026 earnings guidance; CMS finalizes higher 2027 Medicare Advantage payment rates.Mixed▶
Molina Healthcare reaffirmed 2026 earnings guidance with Q1 earnings release April 22 and conference call April 23. CMS finalized higher 2027 Medicare Advantage payment rates, benefiting Molina. Billionaire Seth Klarman initiated new position. However, stock plunged 33% in February after weak Q4 guidance. Company slashed 2026 EPS guidance to $5. Investor Day May 8.
Apr 13Molina Healthcare buoyed by higher 2027 Medicare Advantage rates; Klarman takes new position.Positive▶
CMS finalized higher 2027 Medicare Advantage payment rates benefiting Molina Healthcare. BofA analyst Kevin Fischbeck raised price target to $152 from $145 but kept Underperform rating. Billionaire investor Seth Klarman took new position in the company.
Apr 10Molina Healthcare faces Q4 earnings miss; CEO signals confidence with insider share purchase amid 2027 MA rate gains.Mixed▶
Molina Healthcare reported mixed Q4 2025 results with higher revenue but adjusted loss per share missing expectations. Management forecast 2026 profit below Wall Street estimates. CMS finalized higher 2027 Medicare Advantage payment rates benefiting MOH. CEO Mark Bertolini made significant insider share purchases. Stock down 59.23% over past year but up 6.2% in past week. Consensus Hold with $157.15 target.
Apr 9Molina Healthcare navigates S&P 500 removal amid Q4 challenges and Medicare strategy shiftNegative▶
Molina Healthcare facing significant challenges following disappointing Q4 2025 earnings. Company exiting traditional Medicare Advantage Part D product for 2027. Set for S&P 500 removal amid concerns over medical cost trends and government program reliance. January 2026 workforce development partnership created 15,000 home health aide positions across 26 states. Senior Whole Health rebranded as Molina Healthcare in Massachusetts effective January 1. Stock down 59.23% YoY despite recent 2.62% 24-hour gain. Earnings April 22.
Apr 8Molina Healthcare reports disastrous Q4 with 94.6% MCR; slashes 2026 EPS guidance to $5, exits Medicare Part DNegative▶
Molina Healthcare announced disappointing Q4 2025 results with 94.6% medical cost ratio and net loss, prompting significant 2026 EPS guidance cut to $5. Company exiting Medicare Advantage Part D (MAPD) for 2027 citing underperformance. Management views 2026 as Medicaid industry margin trough. Q1 2026 earnings April 22, 2026.
Apr 7No significant overnight updatesNeutral▶
No material news in the last 48 hours.
Apr 6Molina removed from S&P 500; Q4 2025 loss per share; cautious 2026 outlook.Negative▶
Molina Healthcare removed from S&P 500 index. Q4 2025 loss per share citing $2.50/share impact from new Medicaid contract implementation and Medicare Advantage Part D underperformance (exiting product for 2027). Partnered with HealthStream MissionCare Collective. Earnings April 22.
Apr 3Molina Healthcare faces headwinds after S&P 500 removal, with director equity grants and April 22 earnings release scheduled.Neutral▶
Molina Healthcare faces challenges after being removed from the S&P 500 index and dropped from two major equity indices in March 2026. Directors received equity grants on April 1. Q1 2026 earnings scheduled after market close on April 22. Investor Day planned for May 8.
Apr 2Molina Healthcare reports Q4 shock loss of -$2.75 EPS vs $0.34 expected; slashes 2026 EPS guidance to $5 from $13.71 consensus.Negative▶
Molina Healthcare reported devastating Q4 2025 adjusted loss of -$2.75 per share, missing expectations of $0.34 by massive margin. Stock plunged 28% in premarket trading. Company cut 2026 EPS guidance to $5.00 from consensus $13.71 due to $1.50/share impact from Florida CMS Medicaid implementation and $1.00/share traditional Medicare Advantage underperformance. Exiting MAPD for 2027. Removed from S&P 500 index. Analyst consensus cautious with mostly Hold ratings.
Apr 1Molina Healthcare down 1.91%; projects 72.4% earnings decline ahead of April 22 earnings call.Negative▶
Molina faces significant challenges with analysts projecting 72.4% decline in quarterly earnings. Company forecast annual profit below estimates citing increased Obamacare plan costs. Stock excluded from S&P 500 after 55% decline. Stock at $133.30.
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| UNHUNITEDHEALTH | $370.09 | -0.11% | +31.7% | 17.9x | 0.41 | $336.5B |
| ELVELEVANCE | $373.38 | -0.81% | +24.4% | 12.9x | 0.50 | $81.7B |
| HUMHUMANA | $234.67 | -0.75% | +29.4% | 15.5x | 0.45 | $28.4B |
| CNCCENTENE | $53.45 | -0.45% | +51.7% | 12.3x | 0.59 | $26.5B |
| MOHMOLINA | $192.82 | -0.92% | +35.8% | 21.9x | 0.55 | $10.1B |
| LLYELI | $964.50 | +3.20% | +0.8% | 22.2x | 0.50 | $834.9B |
Key Fundamentals
RSI (14-Day)
52-Week Range
Moving Averages
Price above both MAs — bullish structure.